Listen to Roswellness Radio any time you want. The shows, originally broadcast on WBEN (930 AM/107.7 FM), feature interviews with Roswell Park clinicians and researchers about the latest in cancer research, treatment, prevention and survivorship issues. Listen to or download podcasts of archived shows.
Dr. Philip McCarthy, Director of Blood & Marrow Transplant, describes this rare blood cancer and a major recent study he led involving treatment with the drug lenalidomide following stem-cell transplant. Steven Rukavina describes his experience with multiple myeloma: "[RPCI staff] made me feel like I was their only patient most of the time."
Many cancer patients get access to the most advanced therapies available by participating in clinical trials, or clinical research studies. Alex Adjei, MD, PhD, Katherine Anne Gioia Chair in Cancer Medicine and Senior Vice President of Clinical Research, and Eunice Wang, MD, Associate Professor of Oncology in the Department of Medicine, explain the role of clinical research studies in cancer care and talk about several new trials that are giving hope to patients at RPCI.
Graham Warren, MD, MPH, formerly of Roswell Park, and Andrew Hyland, PhD, Research Scientist in the Department of Health Behavior, talk about new research from RPCI on the impacts of continued tobacco use for cancer patients as well as new data released in a report from the U.S. Surgeon General.
New Research on the Types of Breast Cancer with Drs. Christine Ambrosone, Stephen Edge and Carl Morrison
RPCI researchers recently participated in a landmark study that provided insights into the different types of breast cancer and the genetic factors involved in their development. Christine Ambrosone, PhD, Chair of the Department of Cancer Prevention and Control, Stephen Edge, MD, FACS, former RPCI Breast Center Medical Director and former RPCI Chief of Breast Surgery, and Carl Morrison, MD, DVM, Clinical Chief of the Department of Pathology & Laboratory Medicine, take part in a multidisciplinary discussion about this research and how it will impact the future of cancer treatment.
Meet some of the newest members of our team and hear how they'recontributing to RPCI's mission. Guests: Christopher Choi, PhD, Director, Therapeutic Cell Production Facility; Carmelo Gaudioso, Director of Medical Information; and Shicha Kumar, MD, FACS, Assistant Professor, Department of Surgical Oncology.
A conversation with two of our newest physician faculty members — gynecologic oncologist Stacey Akers, MD, and gastrointestinal surgeon Steven Nurkin, MD, MS, FACS. Drs. Akers and Nurkin, both Assistant Professors of Oncology at the Institute, talk about the interests that steered them toward oncology, and to their fields in particular, and about the fellowship programs that drew both of them to Western New York and to RPCI.
From bone scans to SIR spheres and radioactive iodine therapy, nuclear medicine is an important part of cancer care today. Zachary Grossman, MD, FACR, Chair of Diagnostic Radiology & Nuclear Medicine, and Chief Nuclear Medicine Technologist John Warner talk about how these tools and approaches are used in a variety of imaging procedures and cancer treatments.